Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Vibrio Flagellar Synthesis.

Echazarreta MA, Klose KE.

Front Cell Infect Microbiol. 2019 May 1;9:131. doi: 10.3389/fcimb.2019.00131. eCollection 2019. Review.

2.

Acinetobacter baumannii Gastrointestinal Colonization Is Facilitated by Secretory IgA Which Is Reductively Dissociated by Bacterial Thioredoxin A.

Ketter PM, Yu JJ, Guentzel MN, May HC, Gupta R, Eppinger M, Klose KE, Seshu J, Chambers JP, Cap AP, Arulanandam BP.

MBio. 2018 Jul 10;9(4). pii: e01298-18. doi: 10.1128/mBio.01298-18.

3.

Vibrio2017: the seventh international conference on the biology of Vibrios.

Klose KE, Satchell KJF.

J Bacteriol. 2018 Jun 4;200(15):e00304-18. doi: 10.1128/JB.00304-18. [Epub ahead of print]

4.

A Critical Region in the FlaA Flagellin Facilitates Filament Formation of the Vibrio cholerae Flagellum.

Echazarreta MA, Kepple JL, Yen LH, Chen Y, Klose KE.

J Bacteriol. 2018 Jul 10;200(15). pii: e00029-18. doi: 10.1128/JB.00029-18. Print 2018 Aug 1.

5.

Closed Genome Sequence of Vibrio cholerae O1 El Tor Inaba Strain A1552.

Allué-Guardia A, Echazarreta M, Koenig SSK, Klose KE, Eppinger M.

Genome Announc. 2018 Mar 1;6(9). pii: e00098-18. doi: 10.1128/genomeA.00098-18.

6.

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis.

Nguyen JQ, Zogaj X, Adelani AA, Chu P, Yu JJ, Arulanandam BP, Klose KE.

J Vis Exp. 2017 Sep 30;(127). doi: 10.3791/56123.

PMID:
28994770
7.

Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida.

Sarva ST, Waldo RH, Belland RJ, Klose KE.

PLoS One. 2016 Aug 18;11(8):e0158631. doi: 10.1371/journal.pone.0158631. eCollection 2016.

8.

M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis.

Cunningham AL, Guentzel MN, Yu JJ, Hung CY, Forsthuber TG, Navara CS, Yagita H, Williams IR, Klose KE, Eaves-Pyles TD, Arulanandam BP.

PLoS One. 2016 Apr 21;11(4):e0153402. doi: 10.1371/journal.pone.0153402. eCollection 2016.

9.

Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates.

Chu P, Cunningham AL, Yu JJ, Nguyen JQ, Barker JR, Lyons CR, Wilder J, Valderas M, Sherwood RL, Arulanandam BP, Klose KE.

PLoS Pathog. 2014 Oct 23;10(10):e1004439. doi: 10.1371/journal.ppat.1004439. eCollection 2014 Oct.

10.

RNA thermometer controls temperature-dependent virulence factor expression in Vibrio cholerae.

Weber GG, Kortmann J, Narberhaus F, Klose KE.

Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14241-6. doi: 10.1073/pnas.1411570111. Epub 2014 Sep 16.

11.

Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112ΔiglB::fljB.

Cunningham AL, Dang KM, Yu JJ, Guentzel MN, Heidner HW, Klose KE, Arulanandam BP.

Vaccine. 2014 Sep 8;32(40):5234-40. doi: 10.1016/j.vaccine.2014.07.038. Epub 2014 Jul 19.

12.

Vibrio cholerae persisted in microcosm for 700 days inhibits motility but promotes biofilm formation in nutrient-poor lake water microcosms.

Jubair M, Atanasova KR, Rahman M, Klose KE, Yasmin M, Yilmaz O, Morris JG Jr, Ali A.

PLoS One. 2014 Mar 25;9(3):e92883. doi: 10.1371/journal.pone.0092883. eCollection 2014.

13.

Lipidation of the FPI protein IglE contributes to Francisella tularensis ssp. novicida intramacrophage replication and virulence.

Nguyen JQ, Gilley RP, Zogaj X, Rodriguez SA, Klose KE.

Pathog Dis. 2014 Oct;72(1):10-8. doi: 10.1111/2049-632X.12167. Epub 2014 May 8.

14.

Draft Genome Sequence of the Fish Pathogen Piscirickettsia salmonis.

Eppinger M, McNair K, Zogaj X, Dinsdale EA, Edwards RA, Klose KE.

Genome Announc. 2013 Nov 7;1(6). pii: e00926-13. doi: 10.1128/genomeA.00926-13.

15.

An HD-GYP cyclic di-guanosine monophosphate phosphodiesterase with a non-heme diiron-carboxylate active site.

Miner KD, Klose KE, Kurtz DM Jr.

Biochemistry. 2013 Aug 13;52(32):5329-31. doi: 10.1021/bi4009215. Epub 2013 Jul 29.

16.

Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model.

Signarovitz AL, Ray HJ, Yu JJ, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP.

PLoS One. 2012;7(10):e47639. doi: 10.1371/journal.pone.0047639. Epub 2012 Oct 30.

17.

A bacterial hemerythrin domain regulates the activity of a Vibrio cholerae diguanylate cyclase.

Schaller RA, Ali SK, Klose KE, Kurtz DM Jr.

Biochemistry. 2012 Oct 30;51(43):8563-70. doi: 10.1021/bi3011797. Epub 2012 Oct 18.

18.

Cyclic di-GMP stimulates biofilm formation and inhibits virulence of Francisella novicida.

Zogaj X, Wyatt GC, Klose KE.

Infect Immun. 2012 Dec;80(12):4239-47. doi: 10.1128/IAI.00702-12. Epub 2012 Sep 17.

19.

Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis.

Rodriguez AR, Yu JJ, Guentzel MN, Navara CS, Klose KE, Forsthuber TG, Chambers JP, Berton MT, Arulanandam BP.

J Immunol. 2012 Jun 1;188(11):5604-11. doi: 10.4049/jimmunol.1200039. Epub 2012 Apr 23.

20.

Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.

Sanapala S, Yu JJ, Murthy AK, Li W, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP.

Infect Immun. 2012 Jun;80(6):2177-85. doi: 10.1128/IAI.00036-12. Epub 2012 Apr 9.

21.

Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition.

Hankins JV, Madsen JA, Giles DK, Childers BM, Klose KE, Brodbelt JS, Trent MS.

Mol Microbiol. 2011 Sep;81(5):1313-29. doi: 10.1111/j.1365-2958.2011.07765.x. Epub 2011 Jul 18.

22.

N-terminal residues of the Vibrio cholerae virulence regulatory protein ToxT involved in dimerization and modulation by fatty acids.

Childers BM, Cao X, Weber GG, Demeler B, Hart PJ, Klose KE.

J Biol Chem. 2011 Aug 12;286(32):28644-55. doi: 10.1074/jbc.M111.258780. Epub 2011 Jun 14.

23.

Evasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein C.

Nallaparaju KC, Yu JJ, Rodriguez SA, Zogaj X, Manam S, Guentzel MN, Seshu J, Murthy AK, Chambers JP, Klose KE, Arulanandam BP.

PLoS One. 2011 Mar 31;6(3):e18201. doi: 10.1371/journal.pone.0018201.

24.

Tryptophan prototrophy contributes to Francisella tularensis evasion of gamma interferon-mediated host defense.

Chu P, Rodriguez AR, Arulanandam BP, Klose KE.

Infect Immun. 2011 Jun;79(6):2356-61. doi: 10.1128/IAI.01349-10. Epub 2011 Apr 4.

25.

The complexity of ToxT-dependent transcription in Vibrio cholerae.

Weber GG, Klose KE.

Indian J Med Res. 2011 Feb;133:201-6. Review.

26.

Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation.

Murthy AK, Chaganty BK, Troutman T, Guentzel MN, Yu JJ, Ali SK, Lauriano CM, Chambers JP, Klose KE, Arulanandam BP.

PLoS One. 2011 Feb 9;6(2):e16847. doi: 10.1371/journal.pone.0016847.

27.

A bacterial two-hybrid system that utilizes Gateway cloning for rapid screening of protein-protein interactions.

Karna SL, Zogaj X, Barker JR, Seshu J, Dove SL, Klose KE.

Biotechniques. 2010 Nov;49(5):831-3. doi: 10.2144/000113539.

28.

Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification.

Rodriguez AR, Yu JJ, Murthy AK, Guentzel MN, Klose KE, Forsthuber TG, Chambers JP, Berton MT, Arulanandam BP.

Mucosal Immunol. 2011 Mar;4(2):217-26. doi: 10.1038/mi.2010.59. Epub 2010 Sep 22.

29.

Vibrio2009: the third international conference on the biology of Vibrios.

Thompson FL, Thompson CC, Vicente AC, Klose KE; AVIB Group.

Mol Microbiol. 2010 Sep;77(5):1065-71. doi: 10.1111/j.1365-2958.2010.07286.x.

30.

Role of Vibrio polysaccharide (vps) genes in VPS production, biofilm formation and Vibrio cholerae pathogenesis.

Fong JC, Syed KA, Klose KE, Yildiz FH.

Microbiology. 2010 Sep;156(Pt 9):2757-69. doi: 10.1099/mic.0.040196-0. Epub 2010 May 13.

31.

The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studies.

Ray HJ, Chu P, Wu TH, Lyons CR, Murthy AK, Guentzel MN, Klose KE, Arulanandam BP.

PLoS One. 2010 Apr 1;5(4):e9952. doi: 10.1371/journal.pone.0009952.

32.

The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence.

Barker JR, Chong A, Wehrly TD, Yu JJ, Rodriguez SA, Liu J, Celli J, Arulanandam BP, Klose KE.

Mol Microbiol. 2009 Dec;74(6):1459-70.

33.

Genetic manipulation of francisella tularensis.

Zogaj X, Klose KE.

Front Microbiol. 2011 Jan 5;1:142. doi: 10.3389/fmicb.2010.00142. eCollection 2010.

34.

Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.

Yu JJ, Goluguri T, Guentzel MN, Chambers JP, Murthy AK, Klose KE, Forsthuber TG, Arulanandam BP.

Clin Vaccine Immunol. 2010 Feb;17(2):215-22. doi: 10.1128/CVI.00361-09. Epub 2009 Dec 16.

35.

The ToxT-dependent methyl-accepting chemoreceptors AcfB and TcpI contribute to Vibrio cholerae intestinal colonization.

Chaparro AP, Ali SK, Klose KE.

FEMS Microbiol Lett. 2010 Jan;302(2):99-105. doi: 10.1111/j.1574-6968.2009.01835.x. Epub 2009 Oct 28.

36.

A novel regulatory protein involved in motility of Vibrio cholerae.

Moisi M, Jenul C, Butler SM, New A, Tutz S, Reidl J, Klose KE, Camilli A, Schild S.

J Bacteriol. 2009 Nov;191(22):7027-38. doi: 10.1128/JB.00948-09. Epub 2009 Sep 18.

37.

The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors.

Syed KA, Beyhan S, Correa N, Queen J, Liu J, Peng F, Satchell KJ, Yildiz F, Klose KE.

J Bacteriol. 2009 Nov;191(21):6555-70. doi: 10.1128/JB.00949-09. Epub 2009 Aug 28.

38.

Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.

Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP.

Vaccine. 2009 Sep 18;27(41):5554-61. doi: 10.1016/j.vaccine.2009.07.034. Epub 2009 Aug 3.

39.

Targeted gene disruption in Francisella tularensis by group II introns.

Rodriguez SA, Davis G, Klose KE.

Methods. 2009 Nov;49(3):270-4. doi: 10.1016/j.ymeth.2009.04.011. Epub 2009 May 4.

40.

Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.

Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, Guentzel MN, Arulanandam BP.

Clin Vaccine Immunol. 2009 Apr;16(4):444-52. doi: 10.1128/CVI.00405-08. Epub 2009 Feb 11.

41.

Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis.

Sorci L, Martynowski D, Rodionov DA, Eyobo Y, Zogaj X, Klose KE, Nikolaev EV, Magni G, Zhang H, Osterman AL.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3083-8. doi: 10.1073/pnas.0811718106. Epub 2009 Feb 9.

42.

Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India.

Chatterjee S, Ghosh K, Raychoudhuri A, Chowdhury G, Bhattacharya MK, Mukhopadhyay AK, Ramamurthy T, Bhattacharya SK, Klose KE, Nandy RK.

J Clin Microbiol. 2009 Apr;47(4):1087-95. doi: 10.1128/JCM.02026-08. Epub 2009 Jan 21.

43.

The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression.

Chong A, Wehrly TD, Nair V, Fischer ER, Barker JR, Klose KE, Celli J.

Infect Immun. 2008 Dec;76(12):5488-99. doi: 10.1128/IAI.00682-08. Epub 2008 Oct 13.

44.

Characterization of the Francisella tularensis subsp. novicida type IV pilus.

Zogaj X, Chakraborty S, Liu J, Thanassi DG, Klose KE.

Microbiology. 2008 Jul;154(Pt 7):2139-50. doi: 10.1099/mic.0.2008/018077-0.

PMID:
18599841
45.

Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4.

Ketavarapu JM, Rodriguez AR, Yu JJ, Cong Y, Murthy AK, Forsthuber TG, Guentzel MN, Klose KE, Berton MT, Arulanandam BP.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9313-8. doi: 10.1073/pnas.0707636105. Epub 2008 Jun 30.

46.

Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape.

Mohapatra NP, Soni S, Reilly TJ, Liu J, Klose KE, Gunn JS.

Infect Immun. 2008 Aug;76(8):3690-9. doi: 10.1128/IAI.00262-08. Epub 2008 May 19.

47.

CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.

Powell HJ, Cong Y, Yu JJ, Guentzel MN, Berton MT, Klose KE, Murthy AK, Arulanandam BP.

Immunol Cell Biol. 2008 Aug-Sep;86(6):515-22. doi: 10.1038/icb.2008.31. Epub 2008 Apr 22.

PMID:
18427567
48.

Targeted inactivation of francisella tularensis genes by group II introns.

Rodriguez SA, Yu JJ, Davis G, Arulanandam BP, Klose KE.

Appl Environ Microbiol. 2008 May;74(9):2619-26. doi: 10.1128/AEM.02905-07. Epub 2008 Feb 29.

49.

The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge.

Yu JJ, Raulie EK, Murthy AK, Guentzel MN, Klose KE, Arulanandam BP.

Eur J Clin Microbiol Infect Dis. 2008 Apr;27(4):323-5. Epub 2007 Dec 18. No abstract available.

PMID:
18087734
50.

Construction of targeted insertion mutations in Francisella tularensis subsp. novicida.

Liu J, Zogaj X, Barker JR, Klose KE.

Biotechniques. 2007 Oct;43(4):487-90, 492.

Supplemental Content

Loading ...
Support Center